Literature DB >> 16404352

Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix.

N Markeeva1, I Lysovskiy, E Zhuravel, M Soldatkina, V Lyzogubov, V Usenko, V Potapov, P Pogrebnoy.   

Abstract

AIM: To evaluate the influence of human beta-defensin-2 (hBD-2) on viability and proliferation of cultured human epithelial cells and the patterns of hBD-2 expression in normal tissues and early-stage human cervical neoplasia in the relation to proliferative state of these cells.
MATERIALS AND METHODS: The influence of recombinant hBD-2 on viability and proliferation of cultured cells of A431 and M-HeLa lines in vitro was performed by MTT-test, 3H-thymidine incorporation and cell counting techniques. Immunohistochemical analysis of expression of hBD-2 and PCNA in tissue samples (10 normal cases (control), 30 carcinomas of the cervix uteri: 15 - squamous cell carcinoma in situ (Stage 0), and 15 squamous cell carcinoma (Stage Ia)) was performed with the use of anti-hBD-2 and anti-PCNA-mAbs, respectively.
RESULTS: We have revealed that hBD-2 significantly stimulated proliferation of A431 and M-HeLa cells in a concentration-dependent manner in the range of 0.1-2 microg/ml, whilst at higher concentrations (> 3-5 microg/ml) it negatively influenced cell viability. The results of immunohistochemical study have shown that malignant transformation of human cervical epithelium is accompanied by the increase of expression of hBD-2 and PCNA. However, the correlative analysis of the expression of the mentioned markers has revealed no relation between them.
CONCLUSION: The effect of hBD-2 on viability and proliferation of cultured epithelial cells possesses a concentration-dependent character. Expression of hBD-2 is increased in early-stage cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16404352

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  6 in total

1.  Oncogenic relevant defensins: expression pattern and proliferation characteristics of human tumor cell lines.

Authors:  Jochen Winter; Dominik Kraus; Jan Reckenbeil; Rainer Probstmeier
Journal:  Tumour Biol       Date:  2015-12-28

2.  Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes.

Authors:  Manjunatha R Benakanakere; Jiawei Zhao; Johnah C Galicia; Michael Martin; Denis F Kinane
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

Review 3.  Alarmins and immunity.

Authors:  Zhen Han; Joost J Oppenheim
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

Review 4.  Defensins: A Double-Edged Sword in Host Immunity.

Authors:  Dan Xu; Wuyuan Lu
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

Review 5.  Roles of Antimicrobial Peptides in Gynecological Cancers.

Authors:  Chongyi Zhao; Shuo Yan; Yuzhu Song; Xueshan Xia
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

6.  A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.

Authors:  Yue Du; Bo-Yang Shang; Wei-Jin Sheng; Sheng-Hua Zhang; Yi Li; Qing-Fang Miao; Yong-Su Zhen
Journal:  Oncotarget       Date:  2016-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.